Evonik Industries AG (EVKIY) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
EVKIY, $ (piyasa değeri 0) fiyatla Basic Materials işi olan Evonik Industries AG'i temsil ediyor. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 39/100 (ihtiyatlı) olarak derecelendirilmiştir.
Son analiz: 16 Mar 2026Evonik Industries AG (EVKIY) Malzemeler ve Emtia Maruziyeti
Evonik Industries AG, a German-based specialty chemicals company, operates across diverse segments, providing additives, nutrition, smart materials, and performance materials. With a global presence and a focus on innovation, Evonik serves industries ranging from automotive and construction to consumer goods and healthcare, leveraging its broad product portfolio and established market position.
Yatırım Tezi
Evonik Industries AG presents a mixed investment thesis. The company's diverse portfolio of specialty chemicals provides stability across various end markets. The dividend yield of 8.15% may attract income-focused investors. However, a profit margin of 1.9% indicates potential challenges in profitability. Future growth will depend on Evonik's ability to innovate in high-margin specialty chemicals and capitalize on growing demand in sectors like automotive and healthcare. Investors should monitor the company's ability to improve profitability and manage operational costs. The P/E ratio of 25.25 suggests the stock may be fairly valued.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- Market capitalization of $7.59 billion reflects Evonik's significant presence in the specialty chemicals market.
- Dividend yield of 8.15% offers an attractive income stream for investors.
- Profit margin of 1.9% indicates potential areas for improvement in operational efficiency.
- Gross margin of 23.1% demonstrates the value-added nature of Evonik's specialty chemical products.
- Beta of 0.74 suggests lower volatility compared to the broader market.
Rakipler & Benzerleri
Güçlü Yönler
- Diverse product portfolio across multiple segments.
- Global presence with operations in key regions.
- Strong focus on innovation and research and development.
- Established relationships with major customers in various industries.
Zayıflıklar
- Relatively low profit margin compared to some competitors.
- Exposure to cyclical industries such as automotive and construction.
- Dependence on raw material prices and availability.
- Complexity of managing a large and diverse organization.
Katalizörler
- Ongoing: Expansion in the Asia-Pacific region, driven by increasing demand for specialty chemicals.
- Ongoing: Innovation in sustainable and bio-based chemicals, aligning with environmental awareness.
- Ongoing: Leveraging digital technologies to optimize operations and enhance customer engagement.
- Upcoming: Potential strategic acquisitions and partnerships to expand product portfolio and geographic reach.
- Ongoing: Increasing demand for specialty chemicals in the healthcare sector.
Riskler
- Ongoing: Intense competition from other specialty chemical companies.
- Potential: Economic downturns and fluctuations in demand.
- Potential: Regulatory changes and environmental concerns.
- Potential: Disruptions in supply chains and raw material availability.
- Ongoing: Currency risk associated with the ADR structure.
Büyüme Fırsatları
- Growth Opportunity 1: Expansion in the Asia-Pacific region represents a significant growth opportunity for Evonik. The increasing demand for specialty chemicals in countries like China and India, driven by growing industrialization and urbanization, offers substantial market potential. Evonik can leverage its existing presence and invest in new facilities and partnerships to capitalize on this growth, targeting specific sectors like automotive and construction. This expansion could contribute significantly to revenue growth over the next 3-5 years.
- Growth Opportunity 2: Innovation in sustainable and bio-based chemicals aligns with increasing environmental awareness and regulatory pressures. Evonik can invest in research and development to create new products and solutions that meet the growing demand for sustainable alternatives. This includes developing bio-based polymers, biodegradable additives, and environmentally friendly coatings. This focus on sustainability can differentiate Evonik from competitors and attract environmentally conscious customers, driving long-term growth.
- Growth Opportunity 3: Leveraging digital technologies to optimize operations and enhance customer engagement presents a significant opportunity. Evonik can invest in digital platforms to improve supply chain management, streamline manufacturing processes, and provide customized solutions to customers. This includes using data analytics to optimize product formulations and predict customer needs. Digitalization can improve efficiency, reduce costs, and enhance customer satisfaction, driving revenue growth and profitability.
- Growth Opportunity 4: Strategic acquisitions and partnerships can expand Evonik's product portfolio and geographic reach. Evonik can target companies with complementary technologies and market access to strengthen its position in key segments. This includes acquiring companies specializing in high-growth areas like advanced materials and specialty additives. Strategic partnerships can also provide access to new markets and technologies, accelerating growth and innovation.
- Growth Opportunity 5: Increasing demand for specialty chemicals in the healthcare sector offers a promising growth avenue. Evonik can leverage its expertise in pharmaceutical polymers, amino acids, and other ingredients to develop innovative solutions for drug delivery, medical devices, and nutritional supplements. This includes developing customized formulations and providing technical support to pharmaceutical and healthcare companies. The aging global population and increasing healthcare spending are driving demand in this sector, creating significant growth opportunities for Evonik.
Fırsatlar
- Expansion in emerging markets with high growth potential.
- Increasing demand for sustainable and bio-based chemicals.
- Leveraging digital technologies to improve efficiency and customer engagement.
- Strategic acquisitions and partnerships to expand product portfolio and market reach.
Tehditler
- Intense competition from other specialty chemical companies.
- Economic downturns and fluctuations in demand.
- Regulatory changes and environmental concerns.
- Disruptions in supply chains and raw material availability.
Rekabet Avantajları
- Specialty chemicals expertise: Evonik's extensive knowledge and experience in specialty chemicals provide a competitive advantage.
- Diverse product portfolio: The company's broad range of products and solutions caters to various industries, reducing dependence on any single market.
- Global presence: Evonik's operations in multiple regions provide access to diverse markets and customer bases.
- Strong customer relationships: The company's focus on customized solutions and technical support fosters long-term customer relationships.
EVKIY Hakkında
Founded in 1873 and headquartered in Essen, Germany, Evonik Industries AG has evolved into a leading specialty chemicals company. Originally rooted in coal and steel, the company transitioned to specialty chemicals, focusing on high-value products and solutions. Evonik operates through five segments: Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure. The Specialty Additives segment offers products like polyurethane additives and fumed silicas. The Nutrition & Care segment provides ingredients for consumer goods, animal nutrition, and healthcare. The Smart Materials segment delivers advanced materials for automotive and construction. The Performance Materials segment produces polymer materials and intermediates. The Technology & Infrastructure segment offers site management and engineering services. Evonik serves a global customer base across Asia-Pacific, Europe, the Middle East, Africa, and the Americas. As a subsidiary of RAG-Stiftung, Evonik continues to innovate and expand its portfolio of specialty chemical solutions.
Ne Yaparlar
- Develops and manufactures specialty additives for various industries.
- Produces nutrition and care products for consumer goods, animal nutrition, and healthcare.
- Offers smart materials for automotive, paints, coatings, adhesives, and construction sectors.
- Manufactures performance materials and intermediates for rubber, plastics, and automotive industries.
- Provides technology and infrastructure services, including site management and engineering.
- Supplies hydrogen peroxide and peracetic acid for various applications.
İş Modeli
- Evonik generates revenue by selling specialty chemicals and materials to a diverse range of industries.
- The company focuses on high-value-added products and customized solutions to meet specific customer needs.
- Evonik operates through five segments: Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure.
- The company invests in research and development to innovate new products and improve existing ones.
Sektör Bağlamı
Evonik operates in the specialty chemicals industry, which is characterized by high value-added products and customized solutions. The industry is driven by innovation, sustainability, and increasing demand from end markets like automotive, construction, and healthcare. Competition is intense, with companies like ASGLY and BNTGF vying for market share. Market trends include a focus on sustainable and bio-based chemicals, as well as digitalization and automation in manufacturing processes. The global specialty chemicals market is expected to grow, driven by increasing demand from emerging economies and technological advancements.
Kilit Müşteriler
- Automotive industry: Provides materials for vehicle manufacturing and coatings.
- Construction industry: Supplies additives for concrete, adhesives, and sealants.
- Consumer goods industry: Offers ingredients for personal care products and detergents.
- Healthcare industry: Provides pharmaceutical polymers and amino acids for drug delivery and nutrition.
Finansallar
Grafik & Bilgi
Evonik Industries AG (EVKIY) hisse senedi fiyatı: Price data unavailable
Son Haberler
EVKIY için son haber bulunmamaktadır.
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
EVKIY için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
EVKIY için Wall Street fiyat hedefi analizi.
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, EVKIY'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Yönetim: Christian Kullmann
Chairman of the Executive Board
Christian Kullmann has been Chairman of the Executive Board of Evonik Industries AG since 2017. He previously held various leadership positions within the company, including Chief Strategic Officer and Head of the Advanced Intermediates Business Unit. Kullmann holds a degree in business administration from the University of Münster and has extensive experience in the chemical industry.
Sicil: Under Kullmann's leadership, Evonik has focused on strengthening its position in specialty chemicals and driving innovation. He has overseen strategic acquisitions and partnerships to expand the company's product portfolio and geographic reach. Kullmann has also emphasized sustainability and digitalization as key drivers of future growth.
Evonik Industries AG ADR Bilgileri Sponsorsuz
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. EVKIY is an ADR representing shares of Evonik Industries AG. This allows U.S. investors to invest in Evonik without directly dealing with foreign exchanges.
- Ana Piyasa Sembolü: Essen, DE
- ADR Seviyesi: 1
- ADR Oranı: 1:1
- Ana Piyasa Sembolü: EVKI
EVKIY OTC Piyasa Bilgileri
The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited financial disclosure, may not meet minimum listing standards, and may be subject to higher risks compared to companies listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks requires extra caution and due diligence.
- OTC Katmanı: OTC Other
- Açıklama Durumu: Unknown
- Limited financial disclosure increases the risk of investing in EVKIY.
- Lower trading volume and wider bid-ask spreads can lead to price volatility and illiquidity.
- OTC stocks are subject to less regulatory oversight than exchange-listed stocks.
- The 'OTC Other' tier indicates a higher level of risk compared to other OTC tiers.
- Potential for fraud or manipulation is higher in the OTC market.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Check for any news articles or reports that raise red flags.
- Consult with a financial advisor before investing.
- Understand the risks associated with OTC investing.
- Evonik Industries AG is a well-established company with a long history.
- The company operates in the specialty chemicals industry, which has significant barriers to entry.
- Evonik is a subsidiary of RAG-Stiftung, a reputable organization.
- The company has a global presence and serves a diverse range of industries.
EVKIY Hakkında Sıkça Sorulan Sorular
EVKIY için değerlendirilmesi gereken temel faktörler nelerdir?
Evonik Industries AG (EVKIY) şu anda yapay zeka skoru 39/100, düşük puanı gösteriyor. Temel güçlü yan: Diverse product portfolio across multiple segments.. İzlenmesi gereken birincil risk: Ongoing: Intense competition from other specialty chemical companies.. Bu bir finansal tavsiye değildir.
EVKIY MoonshotScore'u nedir?
EVKIY şu anda MoonshotScore'da 39/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
EVKIY verileri ne sıklıkla güncellenir?
EVKIY fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler EVKIY hakkında ne diyor?
EVKIY için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.
EVKIY'a yatırım yapmanın riskleri nelerdir?
EVKIY için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Ongoing: Intense competition from other specialty chemical companies.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
EVKIY'ın P/E oranı nedir?
EVKIY için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için EVKIY'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.
EVKIY aşırı değerli mi, yoksa düşük değerli mi?
Evonik Industries AG (EVKIY)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
EVKIY'ın temettü verimi nedir?
Evonik Industries AG (EVKIY) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Financial data and market information are based on available sources and may be subject to change.
- The analysis provided is for informational purposes only and should not be considered investment advice.
- OTC market data may be less reliable than exchange-listed data.